Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Hodgkin Disease 8Recurrence 3Lymphoma, T-Cell, Peripheral 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

fludarabine phosphate 3Cyclophosphamide 3Antilymphocyte Serum 3Rituximab 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Methylprednisolone 2Methotrexate 2Melphalan 2Busulfan 2Weights and Measures 1Vincristine 1Thioguanine 1Tacrolimus 1Ritonavir 1Prednisolone 1Polymerase Chain Reaction 1Mercaptopurine 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Indinavir 1Geriatric Assessment 1Gelclair 1Flow Cytometry 1Filgrastim 1Etoposide 1Dexamethasone 1Daunorubicin 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Dendritic Cell Sarcoma, Interdigitating × Brentuximab Vedotin × Clear all
NCT06186986 2024-01-02

CD30 Imaging in Diffuse Large B-cell Lymphoma

University Medical Center Groningen

Phase 3 Unknown
20 enrolled
Sarcoma

Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡